Recent Activity

Loading...

STTK

Shattuck Labs, Inc. · NASDAQ

Performance

-24.15%

1W

-9.21%

1M

+0.24%

3M

+348.68%

6M

+18.93%

YTD

+224.9%

1Y

Profile

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Investment Analysis Report: STTK

Overview:

STTK is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $482.82 million. In this report, we will conduct a detailed analysis of STTK's financial health, earnings and revenue growth, profitability, operating margi...

See more ...

Technical Analysis of STTK 2024-05-10

Overview:

In analyzing the technical indicators for STTK over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...
See more ...

Recent News & Updates